Skip directly to searchSkip directly to the site navigationSkip directly to the page's main content

Complete Health Indicator Report of Incidence of Leukemia

Definition

Incidence rate of leukemia by sub-type for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.

Numerator

Number of new cases of leukemia by sub-type among a defined population in a specified time interval.

Denominator

Defined population in a specified time interval.

Why Is This Important?

During 2018, 943 New Jersey males and 678 females of all ages were diagnosed with leukemias. At this time, we do not know what causes most leukemias.

How Are We Doing?

The four most common types of leukemias occur with differing frequencies in adults versus children. Acute lymphocytic leukemia (ALL) is the most common type of childhood leukemia and also affects adults, especially those age 65 and older. Acute myeloid leukemia (AML) occurs in both adults and children. Chronic lymphocytic leukemia most commonly affects adults over age 55, and rarely occurs in children. Chronic myeloid leukemia (CML) occurs mainly in adults. Leukemia incidence rates and counts by age group are provided for the four most common types of leukemia. Detailed incidence rates and counts by gender and county are provided for the two most common types of leukemia (AML and CLL). Although it is often thought of as a children's disease, most cases of leukemia occur in older adults. Leukemia is ten times more common in adults than in children, and more than half of all leukemia cases occur in people over the age of 65. The lifetime risk of developing leukemia is 1 in 54 for men and 1 in 78 for women.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]

Available Services

The New Jersey Department of Health (NJDOH) has many programs and partnerships related to cancer data and information, cancer resources and cancer prevention. Cancer Epidemiology Services: [https://nj.gov/health/ces/] Interactive New Jersey cancer incidence and mortality data, as well as numerous publications, are available through the NJDOH website for cancer statistics and mapping. [https://www.nj.gov/health/ces/cancer-researchers/cancer-data/index.shtml] Office of Cancer Control and Prevention: [https://www.nj.gov/health/ces/public/resources/occp.shtml] NJ Cancer Education and Early Detection (NJCEED): [https://www.nj.gov/health/ces/public/resources/njceed.shtml] NJ Commission on Cancer Research: [https://www.nj.gov/health/ces/cancer-researchers/njccr.shtml]


Related Indicators

Related Health Status Outcomes Indicators:



Data Tables


NJ Leukemia Incidence, Age-Adjusted Rate of Leukemia by Year and Sex, 1990 - 2018

SexYearAge-Adjusted Rate per 100,000Lower LimitUpper LimitNumer- ator
Record Count: 58
Male199017.716.219.3582
Male199117.816.319.4587
Male199217.015.618.5578
Male199317.315.918.8594
Male199417.516.119.1598
Male199516.815.418.2578
Male199617.416.018.9613
Male199717.215.918.6626
Male199817.215.918.6632
Male199917.616.219.0638
Male200016.815.518.2627
Male200119.818.421.3748
Male200218.016.719.5692
Male200318.617.320.0721
Male200419.217.820.6752
Male200518.016.619.3714
Male200618.417.019.7742
Male200718.617.320.0757
Male200818.116.819.4745
Male200918.517.219.9780
Male201021.720.323.2924
Male201120.419.021.8878
Male201220.619.322.0903
Male201320.018.721.4893
Male201420.319.021.7912
Male201521.119.822.6965
Male201620.919.622.3962
Male201720.018.821.4947
Male201819.618.320.9943
Female199011.110.112.1491
Female199110.69.611.6471
Female199210.99.911.9499
Female199311.410.412.4519
Female19949.89.010.8462
Female199510.89.911.8510
Female199610.29.311.2485
Female199710.89.911.8518
Female199810.39.411.3498
Female199910.29.311.2498
Female200011.010.112.0539
Female200110.910.011.8545
Female200211.010.112.0551
Female200310.910.011.9547
Female200411.210.312.2580
Female200510.69.711.5537
Female200611.710.712.7600
Female200711.410.412.3586
Female200811.210.312.2592
Female200911.210.312.1595
Female201012.011.113.0643
Female201113.012.014.1690
Female201212.611.613.6683
Female201311.911.012.9663
Female201413.712.714.8761
Female201511.810.912.8679
Female201612.011.113.0674
Female201712.912.013.9737
Female201811.610.712.6678

Data Notes

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified.

Data Sources

  • NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]
  • NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]


NJ Leukemia Incidence Age-Adjusted Rate of Leukemia by County, Males 2014-2018

CountyAge-Adjusted Rate per 100,000 MalesLower LimitUpper LimitNumer- ator
Record Count: 22
Atlantic18.915.822.5140
Bergen20.518.822.4527
Burlington22.820.225.8281
Camden19.216.821.9244
Cape May18.313.823.964
Cumberland21.417.026.784
Essex19.017.021.2348
Gloucester23.420.027.2178
Hudson14.812.817.1209
Hunterdon21.917.027.878
Mercer21.218.324.4197
Middlesex18.816.920.9383
Monmouth24.422.026.9428
Morris21.819.324.5302
Ocean22.220.124.5424
Passaic19.116.721.8231
Salem18.712.726.734
Somerset18.315.521.5160
Sussex26.020.932.1100
Union19.317.021.9257
Warren18.613.924.556
New Jersey20.419.821.04,729

Data Notes

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.

Data Sources

  • NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]
  • NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]


NJ Leukemia Incidence Age-Adjusted Rate of Leukemia by County, Females 2014-2018

CountyAge-Adjusted Rate per 100,000 FemalesLower LimitUpper LimitNumer- ator
Record Count: 22
Atlantic9.87.812.192
Bergen12.411.213.8398
Burlington13.311.415.4194
Camden13.111.315.0215
Cape May15.010.820.557
Cumberland11.58.615.253
Essex11.710.313.2274
Gloucester13.010.715.7119
Hudson9.37.910.9163
Hunterdon11.99.015.659
Mercer14.212.016.7157
Middlesex12.411.013.9309
Monmouth13.411.815.2285
Morris13.411.615.4219
Ocean13.411.815.1317
Passaic11.710.013.7174
Salem9.25.115.316
Somerset9.98.012.298
Sussex13.910.518.163
Union12.711.014.6213
Warren13.79.918.649
New Jersey12.412.012.83,529

Data Notes

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.

Data Sources

  • NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]
  • NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]


NJ Leukemia Incidence, Age-Group Specific Rates by Leukemia Subtype, 2014-2018

Subtypes of LeukemiaAge GroupIncidence Rate per 100,000Lower LimitUpper LimitNumer- ator
Record Count: 76
ALL - Acute Lymphoblastic Leukemia<11.00.32.35
ALL - Acute Lymphoblastic Leukemia1-47.76.69.0162
ALL - Acute Lymphoblastic Leukemia5-94.53.85.4123
ALL - Acute Lymphoblastic Leukemia10-142.82.33.580
ALL - Acute Lymphoblastic Leukemia15-191.61.22.246
ALL - Acute Lymphoblastic Leukemia20-241.00.61.427
ALL - Acute Lymphoblastic Leukemia25-291.10.81.632
ALL - Acute Lymphoblastic Leukemia30-340.70.41.120
ALL - Acute Lymphoblastic Leukemia35-390.70.51.121
ALL - Acute Lymphoblastic Leukemia40-441.00.71.530
ALL - Acute Lymphoblastic Leukemia45-491.00.61.430
ALL - Acute Lymphoblastic Leukemia50-540.80.61.228
ALL - Acute Lymphoblastic Leukemia55-590.90.61.330
ALL - Acute Lymphoblastic Leukemia60-641.81.32.449
ALL - Acute Lymphoblastic Leukemia65-691.61.12.235
ALL - Acute Lymphoblastic Leukemia70-741.61.02.326
ALL - Acute Lymphoblastic Leukemia75-792.51.73.629
ALL - Acute Lymphoblastic Leukemia80-842.21.33.519
ALL - Acute Lymphoblastic Leukemia85+1.30.72.213
AML - Acute Myeloid Leukemia<11.80.83.39
AML - Acute Myeloid Leukemia1-40.80.51.317
AML - Acute Myeloid Leukemia5-90.40.20.710
AML - Acute Myeloid Leukemia10-140.70.41.119
AML - Acute Myeloid Leukemia15-190.70.41.119
AML - Acute Myeloid Leukemia20-241.61.22.145
AML - Acute Myeloid Leukemia25-291.10.71.530
AML - Acute Myeloid Leukemia30-341.30.91.837
AML - Acute Myeloid Leukemia35-391.30.91.838
AML - Acute Myeloid Leukemia40-442.51.93.171
AML - Acute Myeloid Leukemia45-492.62.13.382
AML - Acute Myeloid Leukemia50-544.03.44.8133
AML - Acute Myeloid Leukemia55-594.74.05.5150
AML - Acute Myeloid Leukemia60-648.07.09.1217
AML - Acute Myeloid Leukemia65-6911.910.513.5264
AML - Acute Myeloid Leukemia70-7417.815.920.0295
AML - Acute Myeloid Leukemia75-7926.823.929.9314
AML - Acute Myeloid Leukemia80-8430.827.234.7263
AML - Acute Myeloid Leukemia85+28.925.732.4290
CLL - Chronic Lymphocytic Leukemia<1**
CLL - Chronic Lymphocytic Leukemia1-4**
CLL - Chronic Lymphocytic Leukemia5-9**
CLL - Chronic Lymphocytic Leukemia10-14**
CLL - Chronic Lymphocytic Leukemia15-19**
CLL - Chronic Lymphocytic Leukemia20-24**
CLL - Chronic Lymphocytic Leukemia25-29**
CLL - Chronic Lymphocytic Leukemia30-34**
CLL - Chronic Lymphocytic Leukemia35-390.40.20.711
CLL - Chronic Lymphocytic Leukemia40-441.41.01.939
CLL - Chronic Lymphocytic Leukemia45-493.22.63.9101
CLL - Chronic Lymphocytic Leukemia50-545.44.76.3180
CLL - Chronic Lymphocytic Leukemia55-599.88.710.9315
CLL - Chronic Lymphocytic Leukemia60-6415.213.716.7412
CLL - Chronic Lymphocytic Leukemia65-6921.819.923.9483
CLL - Chronic Lymphocytic Leukemia70-7427.525.030.1454
CLL - Chronic Lymphocytic Leukemia75-7935.632.239.2417
CLL - Chronic Lymphocytic Leukemia80-8441.437.246.0354
CLL - Chronic Lymphocytic Leukemia85+45.041.049.4452
CML - Chronic Myeloid Leukemia<1**
CML - Chronic Myeloid Leukemia1-4**
CML - Chronic Myeloid Leukemia5-9**
CML - Chronic Myeloid Leukemia10-140.20.10.56
CML - Chronic Myeloid Leukemia15-190.30.10.69
CML - Chronic Myeloid Leukemia20-240.40.20.712
CML - Chronic Myeloid Leukemia25-290.50.30.915
CML - Chronic Myeloid Leukemia30-341.41.01.939
CML - Chronic Myeloid Leukemia35-391.30.91.838
CML - Chronic Myeloid Leukemia40-441.41.01.939
CML - Chronic Myeloid Leukemia45-491.91.42.458
CML - Chronic Myeloid Leukemia50-542.11.62.668
CML - Chronic Myeloid Leukemia55-592.62.13.283
CML - Chronic Myeloid Leukemia60-643.83.14.6104
CML - Chronic Myeloid Leukemia65-694.63.85.6102
CML - Chronic Myeloid Leukemia70-747.05.88.4116
CML - Chronic Myeloid Leukemia75-7911.09.213.1129
CML - Chronic Myeloid Leukemia80-8412.310.014.9105
CML - Chronic Myeloid Leukemia85+12.210.114.5122

Data Notes

Incidence rates (cases per 100,000 population per year) are age-specific. Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. **Age-specific counts/rates are suppressed if fewer than 5 cases were reported in the specified category. Number of cases (numerator) is the total count of cases in five years.

Data Sources

  • NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]
  • NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]


NJ Leukemia Incidence, Age-Adjusted Rate of Acute Myeloid Leukemia by Year and Sex, 1990 - 2018

SexYearAge-Adjusted Rate per 100,000Lower LimitUpper LimitNumer- ator
Record Count: 58
Male19904.13.44.8132
Male19914.13.44.9139
Male19923.52.94.2123
Male19934.53.85.3156
Male19944.53.85.3158
Male19954.53.85.3157
Male19965.04.25.8175
Male19975.04.35.8184
Male19984.33.75.0163
Male19994.84.15.6174
Male20004.13.54.8153
Male20015.85.06.6219
Male20025.34.66.1203
Male20034.94.25.7188
Male20045.04.35.8192
Male20054.84.25.6189
Male20064.94.35.7199
Male20074.74.05.4186
Male20084.23.64.9173
Male20094.23.64.8173
Male20105.64.96.4234
Male20115.44.76.2230
Male20125.44.76.1231
Male20135.04.45.8224
Male20145.54.86.3247
Male20155.54.86.2248
Male20165.64.96.3258
Male20175.34.76.0245
Male20185.14.55.8245
Female19902.52.03.0109
Female19912.62.13.1112
Female19922.72.33.2126
Female19933.32.83.9149
Female19943.02.63.6142
Female19953.22.73.8149
Female19963.73.24.3175
Female19973.02.53.5143
Female19983.02.63.6145
Female19993.02.63.6147
Female20003.12.63.6151
Female20013.53.04.1176
Female20023.12.63.6152
Female20033.12.73.7158
Female20043.53.04.0177
Female20052.82.33.3141
Female20063.32.83.9173
Female20073.32.83.8166
Female20083.73.24.3198
Female20093.02.63.5160
Female20103.22.73.7169
Female20114.13.54.7213
Female20123.63.14.1195
Female20133.22.73.7178
Female20144.33.74.9240
Female20153.42.93.9193
Female20163.53.04.1196
Female20173.93.44.4217
Female20183.73.24.2214

Data Notes

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified.

Data Sources

  • NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]
  • NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]


NJ Leukemia Incidence, Age-Adjusted Rate of Acute Myeloid Leukemia by County, Males, 2014-2018

CountyAge-Adjusted Rate per 100,000Lower LimitUpper LimitNumer- ator
Record Count: 22
Atlantic5.33.77.438
Bergen5.34.46.3134
Burlington5.84.57.470
Camden5.03.86.464
Cape May6.64.110.224
Cumberland4.42.67.018
Essex5.54.46.798
Gloucester5.64.17.646
Hudson3.52.64.750
Hunterdon7.14.510.926
Mercer5.33.97.150
Middlesex4.94.06.097
Monmouth5.84.77.2100
Morris5.34.16.773
Ocean6.15.07.4116
Passaic5.34.06.863
Salem4.41.98.79
Somerset4.43.16.137
Sussex9.56.413.533
Union5.94.67.477
Warren6.84.110.620
New Jersey5.45.15.71,243

Data Notes

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.

Data Sources

  • NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]
  • NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]


NJ Leukemia Incidence, Age-Adjusted Rate of Acute Myeloid Leukemia by County, Females, 2014-2018

CountyAge-Adjusted Rate per 100,000Lower LimitUpper LimitNumer- ator
Record Count: 22
Atlantic3.32.24.831
Bergen4.03.34.8124
Burlington3.92.95.157
Camden3.12.34.149
Cape May5.13.08.422
Cumberland3.92.26.317
Essex3.62.94.584
Gloucester4.33.05.938
Hudson2.72.03.648
Hunterdon4.42.76.921
Mercer4.63.46.150
Middlesex4.23.45.1108
Monmouth3.83.04.878
Morris3.52.64.655
Ocean4.03.15.093
Passaic3.52.64.651
Salem3.01.07.06
Somerset3.12.14.532
Sussex5.13.08.021
Union3.22.44.256
Warren4.12.46.818
New Jersey3.73.54.01,060

Data Notes

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.

Data Sources

  • NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]
  • NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]


NJ Leukemia Incidence, Age-Adjusted Rate of Chronic Lymphocytic Leukemia by Year and Sex, 1990 - 2018

SexYearAge-Adjusted Rate per 100,000Lower LimitUpper LimitNumer- ator
Record Count: 58
Male19906.35.57.3207
Male19916.55.67.5207
Male19926.65.77.5214
Male19936.15.37.0209
Male19945.95.16.8198
Male19955.44.66.3181
Male19965.54.86.4190
Male19975.34.66.2191
Male19986.05.26.9212
Male19996.25.47.1222
Male20006.55.77.4238
Male20017.86.98.7288
Male20026.45.67.2244
Male20037.56.78.4290
Male20047.97.08.8307
Male20057.06.27.9273
Male20067.26.48.1292
Male20077.26.48.1294
Male20087.36.58.2302
Male20097.46.68.3315
Male20109.08.110.0382
Male20118.47.59.3365
Male20128.57.79.5380
Male20138.27.49.1381
Male20147.66.98.5358
Male20158.47.69.3397
Male20168.37.59.1395
Male20177.97.18.7390
Male20187.26.58.0365
Female19904.03.44.6182
Female19913.52.94.1159
Female19923.02.53.5142
Female19933.63.04.2169
Female19943.22.73.8155
Female19953.63.14.2177
Female19962.52.13.0127
Female19973.22.73.8161
Female19983.12.73.7157
Female19993.32.93.9170
Female20003.63.14.1183
Female20013.93.34.4199
Female20024.03.54.6209
Female20033.73.24.2194
Female20044.13.64.7222
Female20054.13.64.7218
Female20063.93.44.5214
Female20073.83.34.3207
Female20083.32.83.8187
Female20094.23.74.8237
Female20104.94.35.5274
Female20114.43.95.0250
Female20124.64.15.2271
Female20134.13.64.6249
Female20144.43.95.0265
Female20154.43.84.9270
Female20163.83.44.4239
Female20174.54.05.1284
Female20184.13.64.7261

Data Notes

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified.

Data Sources

  • NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]
  • NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]


NJ Leukemia Incidence, Age-Adjusted Rate of Chronic Lymphocytic Leukemia, by County, Males, 2014-2018

CountyAge-Adjusted Rate per 100,000Lower LimitUpper LimitNumer- ator
Record Count: 22
Atlantic7.25.49.457
Bergen8.47.39.6225
Burlington10.18.412.1129
Camden8.06.59.7104
Cape May5.23.28.520
Cumberland8.65.912.134
Essex7.76.49.1141
Gloucester9.17.111.673
Hudson6.35.07.984
Hunterdon7.34.710.828
Mercer9.07.111.186
Middlesex6.95.88.2145
Monmouth10.89.312.4201
Morris9.07.510.7131
Ocean6.85.78.1140
Passaic6.65.28.282
Salem6.03.210.813
Somerset6.95.38.964
Sussex8.15.511.536
Union6.35.07.888
Warren6.33.99.822
New Jersey7.97.58.21,905

Data Notes

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.

Data Sources

  • NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]
  • NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]


NJ Leukemia Incidence, Age-Adjusted Rate of Chronic Lymphocytic Leukemia, by County, Females, 2014-2018

CountyAge-Adjusted Rate per 100,000Lower LimitUpper LimitNumer- ator
Record Count: 22
Atlantic3.22.24.632
Bergen4.74.05.5166
Burlington4.03.15.167
Camden4.03.15.173
Cape May4.42.87.123
Cumberland3.01.65.015
Essex3.73.04.692
Gloucester5.34.07.053
Hudson3.02.23.954
Hunterdon5.33.48.027
Mercer4.53.46.053
Middlesex4.23.45.0108
Monmouth4.63.85.6110
Morris5.64.66.9101
Ocean4.43.65.4117
Passaic3.52.64.556
Salem**
Somerset2.61.73.831
Sussex6.14.28.932
Union5.04.06.288
Warren4.92.78.117
New Jersey4.24.04.51,319

Data Notes

Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.

Data Sources

  • NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]
  • NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]

Page Content Updated On 10/04/2021, Published on 12/03/2021
The information provided above is from the Department of Health's NJSHAD web site (https://nj.gov/health/shad). The information published on this website may be reproduced without permission. Please use the following citation: " Retrieved Tue, 19 March 2024 4:11:31 from Department of Health, New Jersey State Health Assessment Data Web site: https://nj.gov/health/shad ".

Content updated: no date